These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 949335)

  • 1. The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339.
    Borensztajn J; Rone MS; Kotlar TJ
    Biochem J; 1976 Jun; 156(3):539-43. PubMed ID: 949335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart.
    Borensztajn J; Robinson DS
    J Lipid Res; 1970 Mar; 11(2):111-7. PubMed ID: 5418473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the inhibition of lipoprotein lipase by Triton WR 1339.
    Sheorain VS; Nageswara Rao T; Subrahmanyam D
    Enzyme; 1980; 25(2):81-6. PubMed ID: 7379775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-decasaccharides impair the catabolism of chylomicrons.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the metabolism of very-low-density lipoproteins by isolated beating-heart cells and the isolated perfused rat heart. Evidence for collagenase-released extracellular lipoprotein lipase.
    Rajaram OV; Clark MG; Barter PJ
    Biochem J; 1980 Feb; 186(2):431-8. PubMed ID: 6246885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal mediation of rat heart lipoprotein lipase activity after fat feeding.
    Pedersen ME; Wolf LE; Schotz MC
    Biochim Biophys Acta; 1981 Oct; 666(1):191-7. PubMed ID: 6271234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-independent release of lipoprotein lipase activity from perfused rat hearts.
    Bagby GJ
    Biochim Biophys Acta; 1983 Aug; 753(1):47-52. PubMed ID: 6882786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes.
    Hayashi H; Niinobe S; Matsumoto Y; Suga T
    J Biochem; 1981 Feb; 89(2):573-9. PubMed ID: 7240128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormones, amino acids and specific inhibitors on rat heart heparin-releasable lipoprotein lipase and tissue neutral lipase activities during long-term perfusion.
    Stam H; Hülsmann WC
    Biochim Biophys Acta; 1984 Jun; 794(1):72-82. PubMed ID: 6375731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fasting on the clearing factor lipase (lipoprotein lipase) activity of fresh and defatted preparations of rat heart muscle.
    Borensztajn J; Otway S; Robinson DS
    J Lipid Res; 1970 Mar; 11(2):102-10. PubMed ID: 5437474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cold exposure on heart clearing factor lipase and triglyceride utilization in the rat.
    Rogers MP; Robinson DS
    J Lipid Res; 1974 May; 15(3):263-72. PubMed ID: 4827916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats.
    Chajek-Shaul T; Friedman G; Stein O; Shiloni E; Etienne J; Stein Y
    Biochim Biophys Acta; 1989 Feb; 1001(3):316-24. PubMed ID: 2917156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to lipoprotein lipase. Application to perfused heart.
    Schotz MC; Twu JS; Pedersen ME; Chen CH; Garfinkel AS; Borensztajn J
    Biochim Biophys Acta; 1977 Nov; 489(2):214-24. PubMed ID: 922025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of colchicine and cycloheximide on the functional and non-functional lipoprotein lipase fractions of rat heart.
    Borensztajn J; Rone MS; Sandros T
    Biochim Biophys Acta; 1975 Sep; 398(3):394-400. PubMed ID: 1174522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-releasable and nonreleasable lipoprotein lipase in the perfused rat heart.
    Ben-Zeev O; Schwalb H; Schotz MC
    J Biol Chem; 1981 Oct; 256(20):10550-4. PubMed ID: 7287722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase activity of rat cardiac muscle. The intracellular distribution of the enzyme between fractions prepared from cardiac muscle and cells isolated from the hearts of fed and starved animals.
    Chohan P; Cryer A
    Biochem J; 1979 Jul; 181(1):83-93. PubMed ID: 486163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the involvement of lipolytic enzymes in endogenous lipolysis of the isolated rat heart.
    Stam H; Broekhoven-Schokker S; Hülsmann WC
    Biochim Biophys Acta; 1986 Jan; 875(1):87-96. PubMed ID: 3940539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart.
    Wu G; Zhang L; Gupta J; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E908-15. PubMed ID: 17595214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.